Boehringer Ingelheim Corporation
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. is the largest subsidiary of Boehringer Ingelheim Corporation, located in Ridgefield, Connecticut. It is the worldwide Center of Excellence in immunology, inflammatory disease, and cardiovascular research.
Boehringer Ingelheim Roxane, Inc. and Roxane Laboratories, Inc. are located in Columbus, Ohio and are subsidiaries of Boehringer Ingelheim Corporation. These subsidiaries are recognized leaders in researching, manufacturing and packaging brand name and generic medications including oral liquids, tablets and capsules.
The leading producer of sterile injectables for the U.S. pharmaceutical industry, Ben Venue
Laboratories, Inc. is based in Bedford, Ohio. It also markets its own line of generic injectables
to hospitals in North America through its Bedford Laboratories division.
Located in St. Joseph, Missouri, Boehringer Ingelheim Vetmedica, Inc. is a leading supplier of
animal health products for livestock producers and veterinarians. Vetmedica is a Center of Competence
in biologicals research for Boehringer Ingelheim's worldwide animal health business.
A wholly owned subsidiary of the Boehringer Ingelheim Corporation since 1991, Boehringer Ingelheim
Chemicals is located in Petersburg, Virginia. The company produces drug substances and intermediates
for the pharmaceutical industry. Production is carried out in FDA inspected cGMP facilities. The
site has ISO 9002 certification and is DEA licensed for C-II controlled substances.
The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered
in Ingelheim, Germany, it operates globally with 144 affiliates in 45 countries and nearly 36,000
employees. Since it was founded in 1885, the privately-owned company has been committed to researching,
developing, manufacturing and marketing novel products of high therapeutic value for human and
veterinary medicine.